Cel-Sci
CVM
$1.67
Share price
-2.91%
Change (1 day)
-33.20%
Change (1 year)
Categories
Cel-Sci (CVM) - P/B ratio
P/B ratio as of May 2024 : 7.34
According to Cel-Sci
's latest financial reports the company has a price-to-book ratio of 7.34.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Cel-Sci - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 10.7 | 178.4% |
| 2022-12-31 | 3.86 | -35.44% |
| 2021-12-31 | 5.98 | -62.81% |
| 2020-12-31 | 16.1 | -65.99% |
| 2019-12-31 | 47.3 | 60.16% |
| 2018-12-31 | 29.5 | -671.6% |
| 2017-12-31 | -5.16 | -280.47% |
| 2016-12-31 | 2.86 | -79.02% |
| 2015-12-31 | 13.6 | 203.68% |
| 2014-12-31 | 4.49 | 105.24% |
| 2013-12-31 | 2.19 | -69.52% |
| 2012-12-31 | 7.18 | -12.64% |
| 2011-12-31 | 8.22 | 11.11% |
| 2010-12-31 | 7.39 | 35.89% |
| 2009-12-31 | 5.44 | 57.29% |
| 2008-12-31 | 3.46 | -17.36% |
| 2007-12-31 | 4.19 | -116.23% |
| 2006-12-31 | -25.8 | -289.3% |
| 2005-12-31 | 13.6 | 30.28% |
| 2004-12-31 | 10.5 | -52.21% |
| 2003-12-31 | 21.9 | 102.53% |
| 2002-12-31 | 10.8 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.11 | -30.42% | 🇺🇸 USA |
 Amgen AMGN | 25.8 | 251.24% | 🇺🇸 USA |
 Xencor XNCR | 2.24 | -69.48% | 🇺🇸 USA |
 Curis CRIS | 4.86 | -33.74% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1.96 | -73.30% | 🇮🇱 Israel |
 BioCryst Pharmaceuticals
BCRX | -2.39 | -132.52% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 0.3211 | -95.62% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 4.26 | -41.90% | 🇺🇸 USA |